The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity

British Journal of Pharmacology - Tập 105 Số 4 - Trang 849-856 - 1992
M. E. M. Benwell1, David J.K. Balfour
1Department of Pharmacology and Clinical Pharmacology, University of Dundee Medical School.

Tóm tắt

The effects of acute and subchronic nicotine and (+)‐amphetamine on the extracellular levels of dopamine and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in nucleus accumbens (NAc) have been studied in conscious, freely‐moving rats by use of in vivo microdialysis. In rats which had been habituated to the test apparatus for approximately 80 min, the acute subcutaneous (s.c.) administration of nicotine (0.1 or 0.4 mg kg−1) caused a dose‐dependent increase (P < 0.01) in spontaneous activity and evoked significant increases (P < 0.05) in the extracellular levels of DOPAC and HVA. Measurements made 24 h after the last injection of nicotine showed that pretreatment with the higher doses tested (0.4 mg kg−1) resulted in increased basal levels of dopamine (P < 0.01) and decreased basal levels of DOPAC (P < 0.05) in the NAc dialysates. Pretreatment with nicotine (0.1 or 0.4 mg kg−1 daily for 5 days) enhanced the effects of the drug on spontaneous locomotor activity and enhanced the effects of the drug on extracellular levels of dopamine to the extent that the response became significant (P < 0.05). If a dopamine uptake inhibitor, nomifensine, was added to the Ringer solution used to dialyse the probe, the s.c. administration of both acute and subchronic nicotine (0.4 mg kg−1) resulted in significant increases (P < 0.05) in the dopamine concentration in the dialysate. Under these conditions, pretreatment with nicotine prior to the test day prolonged (P < 0.05) the dopamine response to a challenge dose of nicotine. Subcutaneous injections of (+)‐amphetamine (0.2 or 0.5 mg kg−1) evoked dose‐dependent increases in both spontaneous activity and the concentration of dopamine in NAc dialysates. These responses were unaffected by 5 days pretreatment with the drug. The results of this study support the conclusion that the enhanced locomotor response to nicotine observed in animals pretreated with the drug prior to the test day is associated with potentiation of its effects on dopamine secretion in the NAc.

Từ khóa


Tài liệu tham khảo

10.1111/j.1748-1716.1981.tb06827.x

Anderssen K., 1981, Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems, Med. Biol., 59, 170

Balfour D.J.K., 1990, Psychtropic Drugs of Abuse — Section 130 of the International Encyclopedia of Pharmacology and Therapeutics, 453

10.1111/j.1471-4159.1989.tb07243.x

10.1111/j.1476-5381.1983.tb09398.x

Clarke P.B.S., 1988, Evidence that mesolimbic activation underlies the locomotor stimulant action of nicotine in rats, J. Pharmacol. Exp. Ther., 246, 701

10.1007/BF00426372

10.1007/BF02244174

10.1111/j.1476-5381.1984.tb10118.x

10.1016/0006-8993(75)90834-3

10.1016/0014-2999(89)90798-X

10.1016/0165-6147(90)90197-G

10.1073/pnas.85.14.5274

10.1002/cne.901800309

10.1111/j.2042-7158.1989.tb06334.x

10.1016/0014-2999(88)90721-2

10.1007/BF01243356

10.1126/science.7291998

10.1016/0306-4522(80)90127-X

Hutchinson R.R., 1985, Aversive stimulation produces nicotine ingestion in squirrel monkeys, Psychol. Rev., 35, 491

10.1016/0014-2999(86)90629-1

10.1111/j.1471-4159.1991.tb08192.x

10.1002/syn.890050104

10.1016/0006-8993(75)90233-4

10.1016/0006-8993(87)91114-0

10.1016/0091-3057(79)90040-6

Paxinos G., 1986, The Rat Brain in Stereotaxic Coordinates.

10.1016/0006-8993(91)90690-W

10.1007/978-1-4684-3186-5_1

10.1111/j.1476-5381.1990.tb14693.x

10.1016/0006-8993(88)91560-0

10.1007/BF02244075

10.1016/0091-3057(82)90321-5

10.1007/BF00429192

Vale A.L., 1988, Studies on the role of brain dopamine systems in the psychostimulant response to nicotine, Br. J. Pharmacol., 94, 373P

10.1016/0091-3057(89)90048-8

10.1111/j.1471-4159.1988.tb01798.x

10.1037/0033-295X.94.4.469

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 105 Số 4

849-856

Thông tin tác giả